Debt-to-equity of Cellectar Biosciences, Inc. from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cellectar Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • Cellectar Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 76%, a 79% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Cellectar Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 76% -291% -79% 30 Sep 2025
Q2 2025 99% +650% 30 Jun 2025
Q1 2025 105% +358% 31 Mar 2025
Q4 2024 138% +301% 31 Dec 2024
Q3 2024 367% +620% 30 Sep 2024
Q2 2024 -552% -928% -247% 30 Jun 2024
Q1 2024 -253% -352% -355% 31 Mar 2024
Q4 2023 -163% -219% -394% 31 Dec 2023
Q3 2023 -253% -285% -906% 30 Sep 2023
Q2 2023 377% +357% +1794% 30 Jun 2023
Q1 2023 99% +85% +613% 31 Mar 2023
Q4 2022 56% +45% +441% 31 Dec 2022
Q3 2022 31% +23% +261% 30 Sep 2022
Q2 2022 20% +9% +88% 30 Jun 2022
Q1 2022 14% +1% +12% 31 Mar 2022
Q4 2021 10% -6% -37% 31 Dec 2021
Q3 2021 9% -21% -71% 30 Sep 2021
Q2 2021 11% -19% -65% 30 Jun 2021
Q1 2021 12% -19% -60% 31 Mar 2021
Q4 2020 16% -10% -39% 31 Dec 2020
Q3 2020 30% +8% +37% 30 Sep 2020
Q2 2020 30% +12% +63% 30 Jun 2020
Q1 2020 31% +10% +47% 31 Mar 2020
Q4 2019 26% +6% +26% 31 Dec 2019
Q3 2019 22% -1% -6.5% 30 Sep 2019
Q2 2019 18% -10% -36% 30 Jun 2019
Q1 2019 21% -1% -6% 31 Mar 2019
Q4 2018 21% +3% +17% 31 Dec 2018
Q3 2018 23% +7% +44% 30 Sep 2018
Q2 2018 29% +14% +99% 30 Jun 2018
Q1 2018 22% +8% +56% 31 Mar 2018
Q4 2017 18% -6% -24% 31 Dec 2017
Q3 2017 16% -39% -71% 30 Sep 2017
Q2 2017 15% -96% -87% 30 Jun 2017
Q1 2017 14% -273% -95% 31 Mar 2017
Q4 2016 23% -238% -91% 31 Dec 2016
Q3 2016 55% -119% -68% 30 Sep 2016
Q2 2016 110% +4% +3.5% 30 Jun 2016
Q1 2016 287% +141% +96% 31 Mar 2016
Q4 2015 261% +37% +17% 31 Dec 2015
Q3 2015 175% -164% -48% 30 Sep 2015
Q2 2015 107% -857% -89% 30 Jun 2015
Q1 2015 147% -91% -38% 31 Mar 2015
Q4 2014 224% +94% +73% 31 Dec 2014
Q3 2014 339% +264% +351% 30 Sep 2014
Q2 2014 963% +912% +1756% 30 Jun 2014
Q1 2014 238% +208% +697% 31 Mar 2014
Q4 2013 129% +116% +879% 31 Dec 2013
Q3 2013 75% +62% +486% 30 Sep 2013
Q2 2013 52% 30 Jun 2013
Q1 2013 30% 31 Mar 2013
Q4 2012 13% 31 Dec 2012
Q3 2012 13% 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.